15/10/02说明:此前论坛服务器频繁出错,现已更换服务器。今后论坛继续数据库备份,不备份上传附件。

肝胆相照论坛

 

 

肝胆相照论坛 论坛 学术讨论& HBV English 肝活检中乙型肝炎表面抗原表达与临床病理学和生化参数的 ...
查看: 247|回复: 2
go

肝活检中乙型肝炎表面抗原表达与临床病理学和生化参数的 [复制链接]

Rank: 8Rank: 8

现金
62111 元 
精华
26 
帖子
30437 
注册时间
2009-10-5 
最后登录
2022-12-28 

才高八斗

1
发表于 2022-2-8 18:53 |只看该作者 |倒序浏览 |打印
肝活检中乙型肝炎表面抗原表达与临床病理学和生化参数的相关性:一项综合研究
Anil Alpsoy 1 , Haydar Adanir 2 , Zeynep Bayramoglu 1 , Gulsum Ozlem Elpek 3
隶属关系
隶属关系

    1
    病理学系,阿克德尼兹大学,医学院,安塔利亚 07070,土耳其。
    2
    阿克德尼兹大学医学院胃肠病学系,土耳其安塔利亚 07070。
    3
    病理学系,阿克德尼兹大学,医学院,安塔利亚 07070,土耳其。 [email protected]

    PMID:35126853 PMCID:PMC8790405 DOI:10.4254/wjh.v14.i1.260

抽象的

背景:慢性病毒性乙型肝炎 (CHB) 是一种可能危及生命的肝脏疾病,可能会发展为肝功能衰竭和肝硬化。目前,虽然在 CHB 的随访和治疗中使用了不同实验室方法的组合,但在某些情况下这些程序的失败导致了开发新方法的必要性。在 CHB 中,病毒抗原的肝内表达模式,包括乙型肝炎表面抗原 (HBsAg),与炎症的不同阶段有关。然而,许多研究都集中在 HBsAg 染色的胞浆内特性,而肝组织中的 HBsAg 阳性尚未通过客观的定量方法进行评估。

目的:探讨基于图像分析的定量 HBsAg 表达及其染色模式与 CHB 临床病理因素和治疗的关系。

方法:本研究共纳入 140 例来自初治 CHB 感染病例的肝活检。诊断后,所有患者均接受恩替卡韦(0.5 mg)治疗,并每隔三个月进行一次随访。通过图像分析在每个病例的活组织检查的整个组织切片中确定肝脏中免疫组织化学 HBsAg (p-HBsAg) 表达的百分比。还根据 3 种不同的先前定义的分类分别评估免疫组织化学染色模式。

结果:p-HBsAg 与血清乙型肝炎病毒 (HBV) DNA 和 HBsAg 水平呈正相关(P < 0.001)。年轻患者的 p-HBsAg 值显着高于老年患者。当根据 HBeAg 阳性病例中的乙型肝炎 e 抗原 (HBeAg) 状态对各组进行分类时,p-HBsAg 与 HBV DNA、肝炎活动指数 (HAI) 和纤维化评分相关 (P < 0.001)。在该组中,p-HBsAg 和 HBsAg 表达模式也与病毒反应 (VR) 和血清学反应 (SR) 相关 (P < 0.001)。多变量分析显示 p-HBsAg 是 VR 或 SR 的独立预测因子(P < 0.001)。在 HBeAg 阴性患者中,虽然 HBsAg 表达模式与 HAI 和纤维化相关,但在 p-HBsAg、临床病理因素和 VR 之间没有观察到相关性。

结论:在预处理肝活检中,通过定量方法对 HBsAg 表达进行免疫组织化学测定,超出其在细胞内的分布,可能是治疗反应的良好预测指标,尤其是在 HBeAg 阳性病例中。

关键词:纤维化;乙型肝炎;乙型肝炎 e 抗原;乙型肝炎表面抗原;图像分析;免疫组织化学。

©The Author(s)

Rank: 8Rank: 8

现金
62111 元 
精华
26 
帖子
30437 
注册时间
2009-10-5 
最后登录
2022-12-28 

才高八斗

2
发表于 2022-2-8 18:53 |只看该作者
Correlation of hepatitis B surface antigen expression with clinicopathological and biochemical parameters in liver biopsies: A comprehensive study
Anil Alpsoy  1 , Haydar Adanir  2 , Zeynep Bayramoglu  1 , Gulsum Ozlem Elpek  3
Affiliations
Affiliations

    1
    Department of Pathology, Akdeniz University, Medical School, Antalya 07070, Turkey.
    2
    Department of Gastroenterology, Akdeniz University, Medical School, Antalya 07070, Turkey.
    3
    Department of Pathology, Akdeniz University, Medical School, Antalya 07070, Turkey. [email protected].

    PMID: 35126853 PMCID: PMC8790405 DOI: 10.4254/wjh.v14.i1.260

Abstract

Background: Chronic viral B hepatitis (CHB) is a potentially life-threatening liver disease that may progress to liver failure and cirrhosis. Currently, although combinations of different laboratory methods are used in the follow-up and treatment of CHB, the failure of these procedures in some cases has led to the necessity of developing new approaches. In CHB, the intrahepatic expression pattern of viral antigens, including hepatitis B surface antigen (HBsAg), is related to different phases of inflammation. However, many studies have focused on the intracytoplasmic properties of HBsAg staining, and HBsAg positivity in liver tissue has not been evaluated by objective quantitative methods.

Aim: To investigate the relationship of image analysis-based quantitative HBsAg expression and its staining patterns with clinicopathological factors and treatment in CHB.

Methods: A total of 140 liver biopsies from treatment-naïve cases with CHB infection were included in this study. Following diagnosis, all patients were treated with entecavir (0.5 mg) and followed up at three-month intervals. The percentage of immunohistochemical HBsAg (p-HBsAg) expression in the liver was determined in whole tissue sections of biopsies from each case by image analysis. The immunohistochemical staining pattern was also evaluated separately according to 3 different previously defined classifications.

Results: A positive correlation between p-HBsAg and serum levels of hepatitis B virus (HBV) DNA and HBsAg was observed (P < 0.001). The p-HBsAg value was significantly higher in younger patients than in older patients. When the groups were categorized according to the hepatitis B e antigen (HBeAg) status in HBeAg-positive cases, p-HBsAg was correlated with HBV DNA, hepatitis activity index (HAI) and fibrosis scores (P < 0.001). In this group, p-HBsAg and HBsAg expression patterns were also correlated with the viral response (VR) and the serological response (SR) (P < 0.001). Multivariate analysis revealed that p-HBsAg was an independent predictor of either VR or SR (P < 0.001). In HBeAg-negative patients, although HBsAg expression patterns were correlated with both HAI and fibrosis, no relationship was observed among p-HBsAg, clinicopathological factors and VR.

Conclusion: In pretreatment liver biopsies, the immunohistochemical determination of HBsAg expression by quantitative methods, beyond its distribution within the cell, may be a good predictor of the treatment response, especially in HBeAg-positive cases.

Keywords: Fibrosis; Hepatitis B; Hepatitis B e antigens; Hepatitis B surface antigens; Image analysis; Immunohistochemistry.

©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.

Rank: 8Rank: 8

现金
62111 元 
精华
26 
帖子
30437 
注册时间
2009-10-5 
最后登录
2022-12-28 

才高八斗

3
发表于 2022-2-8 18:53 |只看该作者
‹ 上一主题|下一主题
你需要登录后才可以回帖 登录 | 注册

肝胆相照论坛

GMT+8, 2024-7-8 21:43 , Processed in 0.013164 second(s), 11 queries , Gzip On.

Powered by Discuz! X1.5

© 2001-2010 Comsenz Inc.